NieminenT, WalkerCJ, OlkinuoraA, GenutisLK, O'MalleyM, WakelyJr. PE, LaGuardiaL, KoskenvuoL, ArolaJ, LepistoAH, BrockP, YilmazAS, EisfeldA, ChurchJM, PeltomakiP, de la ChapelleA. 2020. Thyroid carcinomas that occur in familial adenomatous polyposis patients recurrently harbor somatic variants in APC, BRAF, and KTM2D. Thyroid, 30:380–388.
2.
JaspersonKW, PatelSG, AhnenDJ. 1998. APC-associated polyposis conditions. In: AdamMP, ArdingerHH, PagonRA, WallaceSE, BeanLJH, StephensK, AmemiyaA (eds) GeneReviews®. University of Washington: Seattle, WA. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1345/
3.
Cancer Genome Atlas ResearchN. 2014. Integrated genomic characterization of papillary thyroid carcinoma. Cell, 159:676–690.
4.
AydemirliMD, van der TuinK, HesFJ, van den OuwelandAMW, van WezelT, KapiteijnE, MorreauH. 2019. A unique case of two somatic APC mutations in an early onset cribriform-morular variant of papillary thyroid carcinoma and overview of the literature. Fam Cancer, 19:15–21.
5.
StrattonMR. 2011. Exploring the genomes of cancer cells: progress and promise. Science, 331:1553–1558.
6.
MasoodiT, SirajAK, SirajS, AzamS, QadriZ, ParvathareddySK, Al-SobhiSS, AlDawishM, AlkurayaFS, Al-KurayaKS. 2019. Evolution and impact of subclonal mutations in papillary thyroid cancer. Am J Hum Genet, 105:959–973.
